CASTLE BIOSCIENCES, INC. Marketable Securities (Current)
CASTLE BIOSCIENCES, INC. (CSTL) had Marketable Securities (Current) of $204.69 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-07-30
- 2026-06-30: Marketable Securities, Current $204.69M.
- 2026-03-31: Marketable Securities, Current $197.92M.
- 2025-12-31: Marketable Securities, Current $182.78M.
- 2025-09-30: Marketable Securities, Current $201.99M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $204.69M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $197.92M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $182.78M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $201.99M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $193.70M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $185.46M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $173.42M 10-K · filed 2026-02-26 |
| 2023-12-31 | $144.26M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |